NCT04265105

Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults

A Pilot Randomised Controlled Superiority Trial of Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: Royal College of Surgeons in Ireland - Medical University of Bahrain · Academic / Other
• Sex: All
• Age: 21 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Investigators will test the superiority of Superiority Trial of Fluticasone-Vilanterol as needed in mild asthma compared to standard of care

Detailed description

single centre randomised control trial with the aim of comparing the superiority of effectiveness and safety of fluticasone-vilanterol versus usual care. In this study there is random allocation of participants to usual care (Any ICS or SABA combination) or fluticasone-vilanterol daily single dose for the relief of symptoms.

Conditions

• Asthma

Interventions

Type	Name	Description
DRUG	fluticasone-vilanterol	LABA-ICS combination Inhaled Long acting Beta agonist and inhaled corticosteroid
DRUG	Standard Preparation	inhaled SABA or Inhaled corticosteroid

Timeline

• Start date: 2021-12-22
• Primary completion: 2023-01-18
• Completion: 2023-01-18
• First posted: 2020-02-11
• Last updated: 2023-03-31

Locations

1 site across 1 country: Bahrain